Rheumatology Archives - Page 5 of 9 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only!

Rheumatology

Proposed rituximab and etanercept biosimilars recommended for approval in Europe

Proposed rituximab and etanercept biosimilars recommended for approval in Europe

NRAS launches video to help raise awareness of new developments in treatment

NRAS launches video to help raise awareness of new developments in treatment

First biosimilar mAb in oncology is granted EU marketing authorisation

First biosimilar mAb in oncology is granted EU marketing authorisation

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

Janssen's biologic guselkumab shows promise in phase 2 trial for the treatment of psoriatic arthritis

Guselkumab shows promise in Phase II trial for the treatment of psoriatic arthritis

Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS

Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS

Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS

Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS

Results from NOR-SWITCH study support switch from Remicade® to Remsima®

Results from NOR-SWITCH study support switch from Remicade® to Remsima®

EMA acceptance for review of marketing authorisation application for sarilumab

EMA acceptance for review of marketing authorisation application for sarilumab

Sandoz's biosimilar etanercept has equivalent efficacy to originator product

Sandoz’s biosimilar etanercept has equivalent efficacy to originator product

UCB’s bimekizumab demonstrates positive results in early development in patients with psoriatic arthritis

UCB’s bimekizumab demonstrates positive results in early development in patients with psoriatic arthritis

Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis

Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis

New campaign to reduce delay in diagnosis for people with axial spondyloarthritis

Campaign to reduce delay in diagnosis for people with axial spondyloarthritis

Siemens Healthcare launches new assay range to improve workload consolidation in the laboratory

Siemens Healthcare launches new assay range to improve workload consolidation in the laboratory

NICE says ‘yes’ to new option for rheumatoid arthritis

NICE says ‘yes’ to new option for rheumatoid arthritis